Medical/Pharmaceuticals
S2S China Announces 2026 Finalists, Ten Standout Teams Set to Pitch Global Investors at Westlake University
SHANGHAI, Sept. 20, 2026 /PRNewswire/ -- The inaugural S2S China Symposium has announced the finalists of its 2026 program. Co-hosted by RA Capital Management and Qiming Venture Partners, S2S China is the China chapter of Science2Startup, an invitation-only symposium connecting top academic resea...
Accro Bioscience Announces First Patient Dosed in Phase IIb Study of AC-101 in Moderate-to-Severe Ulcerative Colitis
NEW YORK and SUZHOU, China, Sept. 20, 2026 /PRNewswire/ -- Accro Bioscience Inc. (Accro Bio), a clinical-stage biotechnology company pioneering the development of novel therapeutics for immune mediated diseases, today announced the dosing of their first patient in the Phase IIb clinical trial of ...
Ping An Good Doctor Launches " Ping An GlobalCare": AI-Powered Multilingual Services Break Down Healthcare Barriers for Expats in China
HONG KONG, Sept. 20, 2026 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited("Ping An Good Doctor" or the "Company"; Stock Code: 1833.HK) recently unveiled its new product "Ping An GlobalCare" (平安跨境康) at the Shenzhen Sci-Tech Innovation Exhibition. Targeting the pain points expats ...
BioShanghai Week 2026 Opens -- Joining Forces to Build a Global Biopharmaceutical Innovation Ecosystem
SHANGHAI, Sept. 20, 2026 /PRNewswire/ -- A news report from Yicai Global:
Fosun Health Hosts First International Oncology Treatment Forum in Foshan; International Oncology Alliance Officially Established
FOSHAN, China, Sept. 20, 2026 /PRNewswire/ -- The first International Oncology Treatment Forum, hosted by Fosun Health, was held in Foshan, Guangdong Province, China. Oncology experts from multiple countries and regions participated in the exchanges, discussing the development of international r...
HONG KONG RADIOLOGIST ADVOCATES HUMAN-CENTRED AI AT UN HUMAN RIGHTS COUNCIL IN GENEVA
Dr. Kevin Lau Chung-hang welcomes deepening Medical AI: AI for Diagnostic Precision, Doctors for Compassionate Care GENEVA and HONG KONG, Sept. 19, 2026 /PRNewswire/ -- Speaking at the 63rd Session of the United Nations Human Rights Council (HRC63) at the Palais des Nations in Geneva, Dr. Kevin ...
NAVER D2SF Invests in AI-Driven Precision Medicine Company ImpriMed
* ImpriMed combines ex vivo functional testing with multimodal AI to support personalized cancer treatment decisions and drug development * The investment is part of ImpriMed's $10 million Series A2 bridge round as the company advances U.S. commercialization and expands into Asia * NAVER D2S...
Jiahui Health Highlights China's Growing Role in Global Medical Tourism at WTO Public Forum 2026
GENEVA, Sept. 18, 2026 /PRNewswire/ -- China is seeing growing momentum in inbound medical tourism, driven by expanding access to innovative therapies, visa facilitation and the development of internationally oriented healthcare services, Dr. John K. Hsiang, Chairman of Jiahui Health Executive Co...
2026 Tang Prize Award Ceremony Honors Six Laureates
Outstanding Achievements for Global Well-Being and Our Shared Future TAIPEI, Sept. 18, 2026 /PRNewswire/ -- The 2026 Tang Prize Award Ceremony brought together all six laureates in Taipei on September 18, with five receiving their awards in person and Biopharmaceutical Science laureate Dr. Steve...
Rosti Group highlights cutting-edge medical solutions at Medical Fair Asia 2026
SINGAPORE, Sept. 18, 2026 /PRNewswire/ -- A report from Ringiertrade. The recently concluded Medical Fair Asia 2026, Southeast Asia's Leading International Healthcare Trade Fair for the medical and healthcare sectors, provided opportunities for leading companies to unveil their products and ser...
A robust adjusted EBIT margin of 18.8%, driven by solid organic revenue growth of 7.4%
PARIS, Sept. 18, 2026 /PRNewswire/ --
ADVANCION RELEASES 2025 SUSTAINABILITY REPORT: "SAFE BY CHOICE. SUSTAINABLE BY DESIGN."
Advancion's fifth annual report highlights the Company's progress in safety, sustainable innovation and responsible operations BUFFALO GROVE, Ill., Sept. 17, 2026 /PRNewswire/ -- Advancion Corporation ("Advancion" or the "Company"), a global leader in life sciences buffers and proprietary specia...
Datasea's AI Agent Digital Marketing Services Enter Scaled Commercial Deployment, with Five Agreements Representing Potential Annualized Service Volume of Up to Approximately US$89.4 Million (RMB600 Million)
Five-customer AI agent services advance into actual delivery; CEO reiterates long-term confidence through a previously disclosed US$1.0 million Rule 10b5-1 share purchase plan BEIJING, Sept. 17, 2026 /PRNewswire/ -- Datasea Intelligent Technology Ltd. (NASDAQ: DTSS) ("Datasea" or the "Company"),...
New Peer-Reviewed Study Confirms Innovative Technology Shatters ESR's Four-Hour Deadline
ALCOR Scientific's iSED® analyzers reshape lab logistics and improve patient care for one of medicine's most widely used tests * Seven times longer stability, independently validated. ESR samples on ALCOR Scientific's iSED analyzer remained accurate for up to 28 hours at room temperature and 4...
ZEISS expands retinal imaging portfolio with new ZEISS ALTA DUO 300
ZEISS' new multimodal solution combines automated OCT and fundus imaging to support simplified and efficient retinal assessment across a broader range of eye care practices. JENA, Germany, Sept. 17, 2026 /PRNewswire/ -- ZEISS Medical Technology, one of the world's leading medical technology comp...
There's No One-Size-Fits-All for Treating Older Adults with Cancer, According to New NCCN Patient Resource
New guideline for patients and caregivers explains the importance of assessments to tailor cancer care to every person, regardless of age. PLYMOUTH MEETING, Pa., Sept. 17, 2026 /PRNewswire/ -- Today, the National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers—is publ...
Dr. Alison Armour agrees to become Chief Medical Officer of Alpha Fusion, as Company Advances Integration of At-211 Businesses with Curadh MTR
— Combining Both Companies' Astatine At-211 Assets, Development Capabilities, and Supply Chains to Create a Global Targeted Alpha Therapy Company — TOKYO, Sept. 17, 2026 /PRNewswire/ -- Alpha Fusion Inc. ("Alpha Fusion"), a clinical-stage company with an advanced At-211 drug platform, and Curadh ...
111 Inc. Receives Unsolicited Preliminary Non-Binding Proposal to Acquire the Company
SHANGHAI, Sept. 17, 2026 /PRNewswire/ -- 111 Inc. ( "111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company in China, today announced that its Board of Directors (the "Board") has received an unsolicited preliminary non-binding proposal letter (the "Proposal") dat...
WuXi XDC Out-Licenses WuXiTecan-2 Payload-Linker Technology Platform to Ona Therapeutics to Advance Novel ADC Research and Development
SHANGHAI, Sept. 17, 2026 /PRNewswire/ -- WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK), a leading global CRDMO (Contract Research, Development, and Manufacturing Organization) specializing in antibody-drug conjugates (ADCs) and other bioconjugates, today announced an out-licensing collab...
Clarivate Reveals Citation Laureates 2026 Recognizing Transformative Scientific Breakthroughs
22 researchers honored for Nobel-class discoveries, including pioneers of GLP-1
medicines and other world-changing advances
LONDON, Sept. 17, 2026 /PRNewswire/ -- Clarivate Plc
Week's Top Stories
Most Reposted
BoomerangFX Launches ChatGPT AI Search Advertising for Aesthetic, Wellness and Private-Pay Healthcare Practices, Powered by AUVIA™ AI Clinic Co-Pilot
[Picked up by 1315 media titles]
2026-11-17 23:03Manulife announces Subordinated Debenture issue
[Picked up by 1205 media titles]
2026-11-17 06:45vVardis Raises $175 Million Ahead of NYSE IPO: NYSE Content Update
[Picked up by 1188 media titles]
2026-11-13 22:11The NYSE Welcomes vVARDIS as a Publicly Listed Company
[Picked up by 1176 media titles]
2026-11-14 13:23Cision Introduces AI-Powered Cision Intelligence to Help Brands See More and Act with Confidence
[Picked up by 1172 media titles]
2026-11-12 23:00